Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer
Condition(s):Male Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast CancerLast Updated:November 5, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Male Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast CancerLast Updated:November 5, 2015Completed
Condition(s):Adult Solid NeoplasmLast Updated:April 3, 2018Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:February 7, 2013Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:December 16, 2013Completed
Condition(s):Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage III Colon Cancer; Stage III Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:September 30, 2013Completed
Condition(s):Lung CancerLast Updated:August 10, 2012Completed
Condition(s):Pancreatic CancerLast Updated:August 10, 2012Completed
Condition(s):Non-Small-Cell Lung CarcinomaLast Updated:November 14, 2013Unknown status
Condition(s):Endometriosis; Uterine Diseases; Endometrial Diseases; Infertility Unexplained; Infertility; Female, NonimplantationLast Updated:November 17, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.